Glenn Baity, EVP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 11,943 shares at $35.00 ($418K) on 2016-07-12, disclosed to the SEC on 2016-07-13.
Open-market sale of $418k ACAD by EVP AND GC. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ACAD | SELL | 2017-10-06 | $1.5M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |